Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Effect of sera from seronegative myasthenia gravis patients on neuromuscular junctions.

Sato R, Imamoto S, Utsnomiya I, Chiba T, Taguchi K, Abe K, Tanaka K, Miyatake T.

Neurol Sci. 2013 Oct;34(10):1735-44. doi: 10.1007/s10072-013-1323-y. Epub 2013 Feb 7.

PMID:
23389808
2.

[Clinical features of myasthenia related with autoantibodies to muscle specific tyrosine kinase (MuSK)].

Sanadze AG, Sidnev DV, Karganov MIu.

Zh Nevrol Psikhiatr Im S S Korsakova. 2010;110(12):72-6. Russian.

PMID:
21311492
3.

Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.

Klooster R, Plomp JJ, Huijbers MG, Niks EH, Straasheijm KR, Detmers FJ, Hermans PW, Sleijpen K, Verrips A, Losen M, Martinez-Martinez P, De Baets MH, van der Maarel SM, Verschuuren JJ.

Brain. 2012 Apr;135(Pt 4):1081-101. doi: 10.1093/brain/aws025. Epub 2012 Mar 6.

4.

[Clinical and electrophysiological peculiarities of seronegative myasthenia].

Shcherbakova NI, Sanadze AG, Sidnev DV, Rudnichenko VA.

Zh Nevrol Psikhiatr Im S S Korsakova. 2008;108(3):4-10. Russian.

PMID:
18427534
5.

Anti-p110 autoantibodies identify a subtype of "seronegative" myasthenia gravis with prominent oculobulbar involvement.

Scuderi F, Marino M, Colonna L, Mannella F, Evoli A, Provenzano C, Bartoccioni E.

Lab Invest. 2002 Sep;82(9):1139-46.

PMID:
12218074
6.

Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis.

Pevzner A, Schoser B, Peters K, Cosma NC, Karakatsani A, Schalke B, Melms A, Kröger S.

J Neurol. 2012 Mar;259(3):427-35. doi: 10.1007/s00415-011-6194-7. Epub 2011 Aug 5.

PMID:
21814823
7.

Seronegative myasthenia gravis.

Vincent A, McConville J, Farrugia ME, Newsom-Davis J.

Semin Neurol. 2004 Mar;24(1):125-33. Review.

PMID:
15229799
8.

Cholinergic neuromuscular hyperactivity in patients with myasthenia gravis seropositive for MuSK antibody.

Punga AR, Flink R, Askmark H, Stålberg EV.

Muscle Nerve. 2006 Jul;34(1):111-5.

PMID:
16453324
9.

Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.

Cole RN, Reddel SW, Gervásio OL, Phillips WD.

Ann Neurol. 2008 Jun;63(6):782-9. doi: 10.1002/ana.21371.

PMID:
18384168
10.

IgG from "seronegative" myasthenia gravis patients binds to a muscle cell line, TE671, but not to human acetylcholine receptor.

Blaes F, Beeson D, Plested P, Lang B, Vincent A.

Ann Neurol. 2000 Apr;47(4):504-10.

PMID:
10762162
11.

Cortactin autoantibodies in myasthenia gravis.

Gallardo E, Martínez-Hernández E, Titulaer MJ, Huijbers MG, Martínez MA, Ramos A, Querol L, Díaz-Manera J, Rojas-García R, Hayworth CR, Verschuuren JJ, Balice-Gordon R, Dalmau J, Illa I.

Autoimmun Rev. 2014 Oct;13(10):1003-7. doi: 10.1016/j.autrev.2014.08.039. Epub 2014 Sep 3.

PMID:
25193850
12.

The effectiveness of thymectomy on seronegative generalized myasthenia gravis: comparing with seropositive cases.

Yuan HK, Huang BS, Kung SY, Kao KP.

Acta Neurol Scand. 2007 Mar;115(3):181-4.

PMID:
17295713
13.

Effect of sera from AChR-antibody negative myasthenia gravis patients on AChR and MuSK in cell cultures.

Farrugia ME, Bonifati DM, Clover L, Cossins J, Beeson D, Vincent A.

J Neuroimmunol. 2007 Apr;185(1-2):136-44. Epub 2007 Mar 1.

PMID:
17335909
14.

IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis.

Leite MI, Jacob S, Viegas S, Cossins J, Clover L, Morgan BP, Beeson D, Willcox N, Vincent A.

Brain. 2008 Jul;131(Pt 7):1940-52. doi: 10.1093/brain/awn092. Epub 2008 May 31.

15.

Effect of sera from myasthenia gravis patients and of alpha-bungarotoxin on acetylcholinesterase during in vitro neuromuscular synaptogenesis.

de la Porte S, Ragueh F, Eymard B, Courbin P, Chapron J, Koenig J.

J Neurol Sci. 1993 Jul;117(1-2):92-102.

PMID:
8410074
16.

Modulation of acetylcholine receptor expression in seronegative myasthenia gravis.

Poea S, Guyon T, Bidault J, Bruand C, Mouly V, Berrih-Aknin S.

Ann Neurol. 2000 Nov;48(5):696-705.

PMID:
11079532
17.

Muscle autoantibodies in myasthenia gravis: beyond diagnosis?

Meriggioli MN, Sanders DB.

Expert Rev Clin Immunol. 2012 Jul;8(5):427-38. doi: 10.1586/eci.12.34. Review.

18.

Eye muscle antibodies in patients with ocular myasthenia gravis: possible mechanism for eye muscle inflammation in acetylcholine-receptor antibody-negative patients.

Gunji K, Skolnick C, Bednarczuk T, Benes S, Ackrell BA, Cochran B, Kennerdell JS, Wall JR.

Clin Immunol Immunopathol. 1998 Jun;87(3):276-81.

PMID:
9646837
19.

Acute severe animal model of anti-muscle-specific kinase myasthenia: combined postsynaptic and presynaptic changes.

Richman DP, Nishi K, Morell SW, Chang JM, Ferns MJ, Wollmann RL, Maselli RA, Schnier J, Agius MA.

Arch Neurol. 2012 Apr;69(4):453-60. doi: 10.1001/archneurol.2011.2200. Epub 2011 Dec 12.

20.

Serological and clinical features of patients with myasthenia gravis in north Indian population.

Suhail H, Subbiah V, Singh S, Behari M.

Int J Neurosci. 2010 Feb;120(2):115-9. doi: 10.3109/00207450903389131.

PMID:
20199203
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk